These proteins form a complex that regulates the mammalian/mechanistic target of rapamycin (mTOR), and the hyperactivation of mTOR, caused by loss of TSC1 or TSC2, is involved in the formation of benign tumors. This evidence concerns the gene MTOR and benign neoplasm.